Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)
Clinical trial NCT03500562 · TERMINATED
Trial details
- NCT number
- NCT03500562
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-08
- Primary completion
- 2019-03-29
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.